Keybanc analyst Noah Zatzkin downgrades Lulus Fashion Lounge (NASDAQ:LVLU) from Overweight to Sector Weight.
FDA Faulted for Working Improperly With Biogen Before Clearing Alzheimer’s Drug
https://www.wsj.com/articles/biogen-aduhelm-fda-approval-congressional-investigation-11672333482